News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Marvell's AI networking and optics revenue is accelerating and the company generates positive free cash flow.
  • Marvell still trades at about 50x P/E and 13x P/S, implying a high valuation that could limit near-term upside.
  • Analysts propose a measured mid-term long trade in Marvell to target a re-rating while protecting capital if growth disappoints.
  • Western Digital posted quarter-to-quarter revenue growth.
  • Western Digital showed margin expansion and generated robust free cash flow.
  • Analysts upgraded WDC into an actionable 45-trading-day long trade with defined entry, stop and target.

Latest Articles

Village Farms Appoints Deepak Anand to Lead Global Government Affairs

Village Farms Appoints Deepak Anand to Lead Global Government Affairs

Village Farms International has appointed Deepak Anand as Vice President of Government Affairs to lead global government relations and regulatory strategies. Anand's extensive experience in cannabis policy and international market development is expected to strengthen Village Farms' position and expansion in global cannabis markets. This strategic …

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Pasithea Therapeutics announced it will present initial clinical data from Part A of its ongoing Phase 1/1b trial of PAS-004, a novel oral MEK inhibitor for neurofibromatosis type 1 (NF1)-associated neurofibromas, at the 2026 European Neurofibromatosis Conference in Vienna. This marks the company's first public disclosure of clinical data for the d…

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics announced a virtual event to present interim Phase 3 REZILIENT3 trial data of zipalertinib plus chemotherapy in lung cancer, recently featured at the IASLC 2026 World Conference on Lung Cancer. The data, presented in a Presidential Symposium, highlights potential advancement in T cell engager therapeutics for cancer treatment.

Highwoods Announces Leasing and Disposition Activity

Highwoods Announces Leasing and Disposition Activity

Highwoods Properties announced signing 1.1 million square feet of second generation leases in Q3 2026, including over 200,000 square feet of new leases, reflecting robust leasing demand. The company closed $74 million in non-core disposals, part of its strategic asset sales totaling $374.8 million this year, aimed at optimizing portfolio and improv…

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc announced its intention to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq by October 2026 and deregister under the Exchange Act. The company plans to rename itself Milk Makeup plc to align with its sole operating brand after selling Obagi Medical. Post-delisting, Waldencast intends to seek quotation on an ove…

Brookfield to Host 2026 Investor Day on September 17

Brookfield to Host 2026 Investor Day on September 17

Brookfield Corporation (NYSE: BN) and Brookfield Asset Management (NYSE: BAM) will hold their Investor Day event in New York on September 17, 2026, offering live webcasts and presentations to provide updates on their business operations and strategic direction. The event aims to inform investors about the company's assets under management and long-…

Markets Brace for Fed Move as Oil Jumps and AI Leaders Urge a Pause

Markets Brace for Fed Move as Oil Jumps and AI Leaders Urge a Pause

Markets are pricing a Federal Reserve rate increase this Wednesday amid limited reassurance from last week's inflation reading and a fresh surge in oil prices after renewed Middle East hostilities. Simultaneously, prominent figures in the AI sector have urged a slowdown in development, prompting declines in AI-linked equities and raising the prospe…

Rollins Offered at a Steep Discount to Quality - A 180-Day Rebound Trade

Rollins Offered at a Steep Discount to Quality - A 180-Day Rebound Trade

Rollins (ROL) is a high-return recurring-revenue services business trading near its 52-week low after a margin miss and follow-on investor lawsuits. Fundamentals remain attractive - strong free cash flow, 37% ROE, moderate leverage and a growing dividend - while technicals show oversold conditions. This trade targets a mean-reversion to normalized …

Cespira™, the Joint Venture between Westport and Volvo Group, reveals how HPDI™ 3.0 advances fuel economy and expands OEM options

Cespira™, the Joint Venture between Westport and Volvo Group, reveals how HPDI™ 3.0 advances fuel economy and expands OEM options

Westport Fuel Systems and Volvo Group's joint venture, Cespira, announced the advanced HPDI 3.0 fuel system that improves fuel economy, hardware durability, and system integration for heavy-duty engines using LNG and bioLNG. The technology supports broader engine configurations and future fuels like hydrogen, with production beginning in late 2026 …

Parsons Operational, Agile, Defense Solutions Ready Now on Department of War’s Digital Marketplaces

Parsons Operational, Agile, Defense Solutions Ready Now on Department of War’s Digital Marketplaces

Parsons Corporation announced that nine of its digital defense solutions have been designated as 'Awardable' across two major Department of War digital marketplaces, Platform One and Tradewinds. This recognition facilitates faster government procurement and deployment of Parsons' innovative, mission-ready defense technologies, enhancing operational…

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Telix Pharmaceuticals has received FDA approval for Pixclara®, a novel radioactive diagnostic PET imaging drug indicated to differentiate recurrent or progressive glioma from treatment-related changes in both adult and pediatric patients. This first FDA-approved FET-PET imaging agent for glioma offers physicians enhanced diagnostic precision and tr…

Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain

Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain

The Elmet Group Co., a NASDAQ-listed U.S. provider of critical materials including tungsten, announced a $450 million committed investment from the U.S. Department of War to enhance domestic tungsten production and processing capabilities. The investment aims to reduce foreign dependence, expand manufacturing facilities in Maine, Michigan, and Ohio…